Top 2026 Clinical Trials Investors in United States, page 5

Investors 41 to 50 of 423, ranked by deals in Clinical Trials. Back to the full list

Investor search results

427 investors found
🌍 United States🏷 Clinical Trials
Craig Asher
Craig Asher
Managing Director at OMX Ventures
Early stage2 in Clinical Trials37 investments 📍 United States
2
in Clinical Trials
EE
Eric Edidin
Family Office / YPO / Board Member
Late stage2 in Clinical Trials8 investments 📍 United States
2
in Clinical Trials
Jared Teo
Jared Teo
Investor | Operator | Engineer | Ex-Goldman Sachs, Wharton
Early stage2 in Clinical Trials10 investments 📍 United States
2
in Clinical Trials
Jeffrey Bornstein
Jeffrey Bornstein
Managing Partner at Generation Capital Partners
Mid stage2 in Clinical Trials13 investments 📍 United States
2
in Clinical Trials
Samir Kaul
Samir Kaul
General Partner at Khosla Ventures
Early stage2 in Clinical Trials28 investments 📍 United States
2
in Clinical Trials
Bill Aliski
Bill Aliski
Board member at X4 Pharmaceuticals
Early stage2 in Clinical Trials5 investments 📍 United States
2
in Clinical Trials
Kyle Lui
Kyle Lui
General Partner at Bling Capital
Early stage2 in Clinical Trials23 investments 📍 United States
2
in Clinical Trials
LL
Lennart Lee
Life Sciences Investor & Entrepreneur
Early stage2 in Clinical Trials35 investments 📍 United States
2
in Clinical Trials
Thomas Luan
Thomas Luan
CEO at Taiji Capital
Early stage2 in Clinical Trials7 investments 📍 United States
2
in Clinical Trials
Mark Carter
Mark Carter
Senior Advisor TA Associates
Mid stage2 in Clinical Trials18 investments 📍 United States
2
in Clinical Trials

Contact all 423 Clinical Trials investors

Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, or let Gritt approve them for you, and it sends from your Gmail.

Start free — contact these investors
Joined by 10,600+ startups · no credit card required